(3R,4S,5S)-tert-butyl 4-(benzyl(methyl)amino)-3-methoxy-5-methylheptanoate
Modify Date: 2024-01-12 11:45:42
(3R,4S,5S)-tert-butyl 4-(benzyl(methyl)amino)-3-methoxy-5-methylheptanoate structure
|
Common Name | (3R,4S,5S)-tert-butyl 4-(benzyl(methyl)amino)-3-methoxy-5-methylheptanoate | ||
|---|---|---|---|---|
| CAS Number | 870640-64-5 | Molecular Weight | 349.508 | |
| Density | 1.0±0.1 g/cm3 | Boiling Point | 426.3±35.0 °C at 760 mmHg | |
| Molecular Formula | C21H35NO3 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 211.6±25.9 °C | |
Use of (3R,4S,5S)-tert-butyl 4-(benzyl(methyl)amino)-3-methoxy-5-methylheptanoateMonomethyl auristatin E intermediate-13 is an intermediate reagent in the synthesis of Monomethyl auristatin E (HY-15162). Monomethyl auristatin E (MMAE) is a microtubule/tubulin inhibitor with anticancer activity. MMAE is widely used as the cytotoxic component (ADC Cytotoxin) of antibody-drug conjugates (ADCs)[1]. |
| Name | 2-Methyl-2-propanyl (3R,4S,5S)-4-[benzyl(methyl)amino]-3-methoxy-5-methylheptanoate |
|---|---|
| Synonym | More Synonyms |
| Description | Monomethyl auristatin E intermediate-13 is an intermediate reagent in the synthesis of Monomethyl auristatin E (HY-15162). Monomethyl auristatin E (MMAE) is a microtubule/tubulin inhibitor with anticancer activity. MMAE is widely used as the cytotoxic component (ADC Cytotoxin) of antibody-drug conjugates (ADCs)[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.0±0.1 g/cm3 |
|---|---|
| Boiling Point | 426.3±35.0 °C at 760 mmHg |
| Molecular Formula | C21H35NO3 |
| Molecular Weight | 349.508 |
| Flash Point | 211.6±25.9 °C |
| Exact Mass | 349.261688 |
| LogP | 4.77 |
| Vapour Pressure | 0.0±1.0 mmHg at 25°C |
| Index of Refraction | 1.492 |
| Heptanoic acid, 3-methoxy-5-methyl-4-[methyl(phenylmethyl)amino]-, 1,1-dimethylethyl ester, (3R,4S,5S)- |
| 2-Methyl-2-propanyl (3R,4S,5S)-4-[benzyl(methyl)amino]-3-methoxy-5-methylheptanoate |